COVID-19

COVID-19 and antithrombotics: What we know now

covid and antithrombotics

At the Roche Diagnostics-sponsored satellite symposium ‘From Basic Research to Clinical Data: the Future of Patient Management’ hosted during the International Society for Haemostasis (ISTH) 2021 congress, Dr Jean M Connors MD gave an insightful presentation on thrombo-inflammation in the COVID-19 era. The disease COVID-19 has been identified as a hypercoagulable state. The development of […]

COVID-19 and antithrombotics: What we know now Read More »

Four ways the global coagulation community responded to the COVID-19 pandemic

101283112_m

Since the onset of the COVID-19 pandemic, mounting evidence has shown that patients with severe infection are more likely to have COVID-associated coagulopathies. The global coagulation community responded rapidly with various societies reviewing available data and providing recommendations and educational resources [1]. Researchers also spearheaded a multi-platform randomised trial to support the community to make

Four ways the global coagulation community responded to the COVID-19 pandemic Read More »

COVID-19 vaccines, blood clots and anticoagulation therapy: insights from Dr Ng Heng Joo

COVID-19 vaccines, blood clots and anticoagulation therapy: insights from Dr Ng Heng Joo

Vaccine-induced thrombotic thrombocytopenia (VITT), a condition characterised by blood clots resulting from COVID-19 vaccinations, is a rare but serious concern in the fight against COVID-19. This Q&A with Dr Ng Heng Joo, Head & Senior Consultant in the Department of Haematology at Singapore General Hospital, explores the pathophysiology, diagnosis of VITT and clinical management of

COVID-19 vaccines, blood clots and anticoagulation therapy: insights from Dr Ng Heng Joo Read More »

How coagulation diagnostics support COVID-19 vaccination and patient management

How coagulation diagnostics support COVID-19 vaccination and patient management

Infection with COVID-19 has been associated with thrombosis, or blood clots, involving the veins and arteries. The risk of blood clots is highest for individuals admitted to hospital with COVID-19 infection, occurring in about 5% of people admitted to a regular hospital ward and up to 20% for those in the intensive care unit (ICU),

How coagulation diagnostics support COVID-19 vaccination and patient management Read More »

COVID passes, ‘self-sovereign identity’ and the future of medical data

COVID passes, ‘self-sovereign identity’ and the future of medical data

Key to returning the world to normal in the COVID era is to have an agreed means of confirming that those who wish to move around have tested negative, been vaccinated, or fulfill whatever criteria authorities decide allow for safe passage. While there are dozens of solutions being explored and piloted, debate still revolves about

COVID passes, ‘self-sovereign identity’ and the future of medical data Read More »

CEO viewpoint: Prof Hans Widjaya on digital health and COVID-19 in Indonesia

CEO viewpoint: Prof Hans Widjaya on digital health and COVID-19 in Indonesia

Founded in 2012, National Hospital in Surabaya is a leading private healthcare facility in Indonesia that has brought many new healthcare technologies to the country, from electronic health records to saliva-based PCR tests. Located on the eastern side of the island of Java, its achievements offer a framework for how other facilities in Indonesia can

CEO viewpoint: Prof Hans Widjaya on digital health and COVID-19 in Indonesia Read More »

Border control policy and COVID diagnostics in Asia: insights from Dr Swee Kheng Khor

Border control policy & covid diagnostics - Dr Khor Swee Kheng

Even with the widespread rollout of vaccines, negative COVID test results remain a requirement for crossing borders in most countries. In this Q&A, global health expert Dr Swee Kheng (“SK”) Khor discusses the current state of border control policy in the Asia Pacific region and the critical role of clinical laboratories in safe travel ecosystems.

Border control policy and COVID diagnostics in Asia: insights from Dr Swee Kheng Khor Read More »

LEADx virtual roundtable addresses India’s COVID surge

LEADx virtual roundtable 2021

In recent months India’s COVID-19 situation has worsened significantly, eclipsing other countries with the second-highest number of cases and, at the time this article was written, the third-highest number of recorded deaths on the planet. At the recent LEADx virtual roundtable discussion moderated by Dr Anil Handoo, Senior Lab Director at BLK Super Speciality Hospital, on 30

LEADx virtual roundtable addresses India’s COVID surge Read More »

COVID health passes and credentials: what clinical labs need to know

COVID health passes and credentials: what clinical labs need to know

Clinical labs face a steep learning curve when integrating themselves into the new world of COVID-related “health passes”—the digital or paper certificates that allow individuals to demonstrate proof of a test result or vaccine record in order to cross borders, join events, enter facilities or otherwise move about the world with greater freedom than is

COVID health passes and credentials: what clinical labs need to know Read More »

Scroll to Top